CRA International earnings and capital actions in focus

CRA International (CRAI) just released second quarter 2026 results alongside multiple capital decisions, including a refinanced credit facility, a quarterly dividend and continued share repurchases, giving investors several fresh data points to assess.

The company reported second quarter sales of US$210.82 million compared with US$186.88 million a year earlier. Net income was US$13.51 million compared with US$12.12 million, with diluted earnings per share from continuing operations of US$2.10 versus US$1.79.

CRA International's latest earnings, dividend affirmation, buyback activity and expanded US$400 million credit facility come against a mixed share price backdrop, with the stock down over the year to date but supported by a 3 year total shareholder return of 64.26% and a 5 year total shareholder return of 95.51%, which point to longer term momentum.

If you are weighing CRA International against other opportunities in the market, this may be a useful moment to broaden your watchlist and check out 19 top founder-led companies

CRA International's share price has slipped this year while sitting well below both analyst targets and an internal fair value estimate. Does that gap flag opportunity or signal that expectations around the stock need adjusting?

Most Popular Narrative: 32.9% Undervalued

Against the last close of $169.31, the most followed narrative for CRA International points to a fair value of $252.50, which implies a sizeable value gap that investors are watching closely.

The surge in global regulatory complexity and heightened enforcement, especially in antitrust, is driving robust and sustained demand for CRA's advisory services, as evidenced by record performance in their Antitrust & Competition Economics practice, this is likely to support higher long-term revenue growth.

Read the complete narrative. Read the complete narrative.

Want to see what underpins that valuation gap? The narrative leans on steady revenue expansion, rising profit margins and a richer future earnings multiple. Curious how those pieces fit together to justify the fair value and price target path?

On these assumptions, the narrative anchors on expected growth in CRA International's earnings and margins, along with ongoing share count reduction that supports higher earnings per share over time. It also incorporates a required return that reflects the company’s consulting profile and sets a hurdle rate for those future cash flows, which is important context for anyone comparing this stock with broader US market opportunities.

Result: Fair Value of $252.50 (UNDERVALUED)

However, CRA International's reliance on robust M&A and antitrust work, along with rising compensation pressure for specialist talent, could challenge the upbeat valuation narrative if conditions change.

Next Steps

The mix of opportunities and concerns around CRA International will feel different for every investor, so it is worth looking through the details yourself and deciding how it fits your goals. To see a concise snapshot of both sides of the story, review the 2 key rewards and 3 important warning signs

Looking for more CRA International investment ideas?

If CRA International has your attention, do not stop here. Use this momentum to scan a wider set of stocks that could fit your portfolio and risk comfort.

• Target stronger value candidates by reviewing companies highlighted in the 52 high quality undervalued stocks that might suit a patient, fundamentals focused approach.
• Strengthen your focus on stability by checking stocks in the 83 resilient stocks with low risk scores to see which businesses score well on resilience.
• Spot potential future standouts early by reviewing the screener containing 21 high quality undiscovered gems and see which lesser known companies match your checklist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.